Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 597 clinical trials
Dynamic Observational Study With PET of 68Ga-HER2-affibody in Anti-HER2 Treatment

Dynamic observationaL study with PET of 68Ga-HER2-affibody in anti-HER2 treatment

pertuzumab
erbb2
capecitabine
HER2
docetaxel
  • 0 views
  • 28 Apr, 2022
  • 1 location
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers

The objectives of this pilot feasibility study, which is on the use of 68-Ga PSMA PET imaging of salivary gland tumours, are to determine the proportion of patients with high PSMA-ligand uptake on Ga-68 PSMA imaging in locally advanced, recurrent or metastatic salivary gland cancers and other rare cancer; and …

  • 0 views
  • 27 Oct, 2022
  • 1 location
The Performance of Multi-tracer Multimodality PET in Lymphoma

Investigating the performance of Multi-tracer Multimodality PET in lymphoma

  • 0 views
  • 01 Oct, 2021
  • 1 location
Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With BL/DLBCL

The trial SCCCG-BL/DLBCL-2017 is a collaborative prospective, multicenters, non-randomized, observational, cohort clinical study with participating centers of the South China Children's Cancer Group-Non-Hodgkin lymphoma group(SCCCG-NHL). The aim of the study is to evaluate efficacy and safety of stratified treatment based on risk factors of childhood and adolescents Burkitt lymphoma(BL)/diffuse large …

cancer
large b-cell lymphoma
burkitt's lymphoma
hodgkin's disease
diffuse large b-cell lymphoma
  • 4 views
  • 26 May, 2022
  • 1 location
Pilot Study Assessing the Effect of Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in Patients With ER+/HER2- Metastatic Breast Cancer

The goal of this study is to evaluate changes in body composition among patients who are treated with cyclin-dependent kinase (CDK) 4/6 inhibitors (abemaciclib, ribociclib, or palbociclib).

bisphosphonate
erbb2
HER2
stage iv breast cancer
palbociclib
  • 2 views
  • 28 Feb, 2022
  • 1 location
ProsTIC Registry of Men Treated With PSMA Theranostics

This is a descriptive, observational, prospective, open-ended, registry utilising electronic data capture to collect information on the outcomes of men treated with prostate specific-membrane antigen (PSMA) theranostics.

  • 0 views
  • 27 Apr, 2022
  • 1 location
Clinical Phenotype and Omics Study of KCNQ2-related Epilepsy

The aims of study on KCNQ2-related epilepsy: (1) establish phenotype database and sample database of KCNQ2-related epilepsy; (2) to establish genotype-phenotype association of KCNQ2-related epilepsy; (3) to study the brain network of KCNQ2-related epilepsy based on multi-modal brain image and EEG data; (4) to find prognostic biomarkers of KCNQ2-related epilepsy …

Accepts healthy volunteers
  • 0 views
  • 27 Dec, 2021
  • 1 location
The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

Most ovarian cancer will relapse after standard therapy. Patients with recurrent ovarian cancer are resistant to platinum. Due to the high heterogeneity between ovarian cancer, individual precise therapy is of great importance. The study will establish ovarian cancer organoids, whose original tissues from the patients with advanced or recurrent ovarian …

recurrent ovarian cancer
cancer of the ovary
  • 0 views
  • 10 Apr, 2022
  • 1 location
Evaluation of Multi-Organ Metabolism and Perfusion in NAFLD by Total Body Dynamic PET Scan on EXPLORER (EXPLORER)

Evaluation of Multi-Organ Metabolism and Perfusion in Non-Alcoholic Fatty Liver Disease (NAFLD) by Total Body Dynamic PET Scan on EXPLORER

MRI
fatty liver
liver disease
Accepts healthy volunteers
blood test
  • 1 views
  • 18 Feb, 2022
  • 1 location
Real-world Study on Comprehensive Treatment of Esophageal Cancer Based on Precision Radiotherapy

Radiotherapy is one of the main treatments for locally advanced esophageal carcinoma (EC). The accuracy of the existing imaging methods in diagnosing and predicting therapeutic efficacy is disappointing, which increases the difficulty in clinical decision-making. In this study, based on a continuous cohort of EC treated with radiotherapy, the clinical …

  • 0 views
  • 11 Oct, 2022
  • 1 location